Myopia Treatment Devices Market Size to Hit USD 38.51 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Myopia Treatment Devices Market

5.1. COVID-19 Landscape: Myopia Treatment Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Myopia Treatment Devices Market, By Product Type

8.1. Myopia Treatment Devices Market Revenue and Volume Forecast, by Product Type

8.1.1. Corrective Lenses

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Surgical Devices

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Therapeutic & Progression Control Devices

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Diagnostic Devices

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Myopia Treatment Devices Market, By End Use

9.1. Myopia Treatment Devices Market Revenue and Volume Forecast, by End Use

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Ambulatory Surgical Centers

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Specialty Eye Care Centers

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Optical Stores & Retail Chains

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global Myopia Treatment Devices Market, By Patient Age Group

10.1. Myopia Treatment Devices Market Revenue and Volume Forecast, by Patient Age Group

10.1.1. Children & Adolescents

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Adults

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Geriatric Population

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Myopia Treatment Devices Market, By Distribution Channel

11.1. Myopia Treatment Devices Market Revenue and Volume Forecast, by Distribution Channel

11.1.1. Direct Sales (Hospitals & Clinics)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Optical Retail Chains

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Online Platforms

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Others

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Myopia Treatment Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by End Use

12.1.3. Market Revenue and Volume Forecast, by Patient Age Group

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by End Use

12.1.5.3. Market Revenue and Volume Forecast, by Patient Age Group

12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by End Use

12.1.6.3. Market Revenue and Volume Forecast, by Patient Age Group

12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by End Use

12.2.3. Market Revenue and Volume Forecast, by Patient Age Group

12.2.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by End Use

12.2.5.3. Market Revenue and Volume Forecast, by Patient Age Group

12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by End Use

12.2.6.3. Market Revenue and Volume Forecast, by Patient Age Group

12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by End Use

12.2.7.3. Market Revenue and Volume Forecast, by Patient Age Group

12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by End Use

12.2.8.3. Market Revenue and Volume Forecast, by Patient Age Group

12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by End Use

12.3.3. Market Revenue and Volume Forecast, by Patient Age Group

12.3.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by End Use

12.3.5.3. Market Revenue and Volume Forecast, by Patient Age Group

12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by End Use

12.3.6.3. Market Revenue and Volume Forecast, by Patient Age Group

12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by End Use

12.3.7.3. Market Revenue and Volume Forecast, by Patient Age Group

12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by End Use

12.3.8.3. Market Revenue and Volume Forecast, by Patient Age Group

12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by End Use

12.4.3. Market Revenue and Volume Forecast, by Patient Age Group

12.4.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by End Use

12.4.5.3. Market Revenue and Volume Forecast, by Patient Age Group

12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by End Use

12.4.6.3. Market Revenue and Volume Forecast, by Patient Age Group

12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by End Use

12.4.7.3. Market Revenue and Volume Forecast, by Patient Age Group

12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by End Use

12.4.8.3. Market Revenue and Volume Forecast, by Patient Age Group

12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by End Use

12.5.3. Market Revenue and Volume Forecast, by Patient Age Group

12.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by End Use

12.5.5.3. Market Revenue and Volume Forecast, by Patient Age Group

12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by End Use

12.5.6.3. Market Revenue and Volume Forecast, by Patient Age Group

12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 13. Company Profiles

13.1. Carl Zeiss Meditec AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Johnson & Johnson Vision Care

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. EssilorLuxottica

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. Alcon Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Bausch + Lomb

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. Hoya Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. CooperVision Inc

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Ziemer Ophthalmic Systems

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. NIDEK Co., Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. Topcon Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The myopia treatment devices market size is expected to increase from USD 18.07 billion in 2024 to USD 38.51 billion by 2034.

The myopia treatment devices market is expected to grow at a compound annual growth rate (CAGR) of around 7.86% from 2025 to 2034.

The major players in the myopia treatment devices market include Carl Zeiss Meditec AG, Johnson & Johnson Vision Care, EssilorLuxottica, Alcon Inc., Bausch + Lomb, Hoya Corporation, CooperVision Inc, Ziemer Ophthalmic Systems, NIDEK Co., Ltd., Topcon Corporation, STAAR Surgical Company, SCHWIND eye-tech-solutions, Oculus Optikgeräte GmbH, Menicon Co., Ltd., Contamac Holdings Limited, Visioneering Technologies, Inc., Medennium Inc., Haag-Streit Group, Luneau Technology Group, and Canon Medical Systems Corporation.

The driving factors of the myopia treatment devices market are the rising prevalence of vision disorders among younger populations and the increasing adoption of advanced corrective technologies.

Asia Pacific region will lead the global myopia treatment devices market during the forecast period 2025 to 2034.